24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Life Sciences
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:28
Full list of Israeli high-tech funding rounds in 2024
19:24
TailorMed raises $40 million in equity and debt to help patients access critical medications
18:17
Why Israeli tech companies are moving to Miami
17:11
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
More stories
Buzz
Most popular
Daily
Weekly
1
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Salesforce seals $1.9 billion cash deal to acquire cloud backup company Own
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news
Life Sciences
5 stories about Life Sciences
CTech’s Monday Roundup of Israeli Tech News
14.05.18
|
CTech
Former Google CEO Eric Schmidt to visit Israel. U.S. Treasury Secretary Mnuchin discusses tax reform with Israeli counterpart. Report says Israel’s life sciences industry is dominated by small scale startups
Israel’s Life Sciences Industry Is Dominated by Small Scale Startups
14.05.18
|
Lilach Baumer
65% of all Israel-based life sciences companies employ 10 people or less, according to a new report
Jerusalem Officials Are Setting Up a Venture Capital Fund Focused on Biotech
30.04.18
|
Asaf Shalev
The city is home to 150 biotech startups, a new report finds
Venture Capital Firm aMoon Aims to Raise $500 Million or More For a Second Fund
17.04.18
|
Lilach Baumer
Established in 2016, aMoon invests in life sciences and healthcare companies, with a focus on Israeli tech
Pontifax Raises a $240 Million Fifth Fund
01.01.18
|
Meir Orbach
Life sciences-focused venture capital firm Pontifax is expected to invest most of the new fund in the pharmaceutical industry
Previous Articles
Please ensure Javascript is enabled for purposes of
website accessibility